GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Hormone Research in Paediatrics, S. Karger AG, Vol. 77, No. 6 ( 2012), p. 388-393
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 The objective of this study was to evaluate the efficacy of recombinant human growth hormone (rhGH) therapy and the influence of genotype on the response to rhGH therapy in children with Noonan syndrome (NS). 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 14 male and 4 female subjects with NS with short stature, whose height was 〈 3rd percentile, were included. The rhGH was subcutaneously administered at a dose of 66 µg/kg/day. Mutations in the 〈 i 〉 PTPN11 〈 /i 〉 gene were identified in 10 subjects (55.6%). Mutations in the 〈 i 〉 SOS1 〈 /i 〉 (2 children, 11.1%), 〈 i 〉 MEK1 〈 /i 〉 (1 child, 5.6%) and 〈 i 〉 KRAS 〈 /i 〉 (1 child, 5.6%) genes were also found. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Height SDS increased from –2.8 ± 0.9 at the start of rhGH therapy to –2.0 ± 0.9 12 months later (p 〈 0.001). Height velocity increased from 5.0 ± 0.9 cm/year in the year before treatment to 8.9 ± 1.6 during treatment (p 〈 0.001). Changes in height SDS, height velocity, and serum IGF-1 level did not differ significantly between those children with or without 〈 i 〉 PTPN11 〈 /i 〉 mutations. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 The rhGH therapy significantly improved the growth velocity and increased the serum IGF-1 level. Long-term correlation between genotype and rhGH therapy responsiveness needs to be addressed in a large population.
    Type of Medium: Online Resource
    ISSN: 1663-2818 , 1663-2826
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2012
    detail.hit.zdb_id: 2540224-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    S. Karger AG ; 2017
    In:  Cells Tissues Organs Vol. 204, No. 5-6 ( 2017), p. 261-269
    In: Cells Tissues Organs, S. Karger AG, Vol. 204, No. 5-6 ( 2017), p. 261-269
    Abstract: As a result of restrictions on animal experimentation, improved skin equivalents (SEs) are needed as alternative test models. This work investigated the effects of avian collagen on the construction of SEs, and to the best of our knowledge is the first study to do so. Hematoxylin and eosin and immunohistochemical staining were used to analyze the SEs. In models containing avian collagen as a dermal equivalent (DE) ingredient, fibroblast proliferation increased by about 60% relative to the control model. Immunohistochemical staining showed that the expression of proliferating cell nuclear antigen (PCNA) and p63 increased in the avian collagen models, while the expression of involucrin, integrin α 〈 sub 〉 6 〈 /sub 〉 , and integrin β 〈 sub 〉 1 〈 /sub 〉 remained unchanged. Next, DEs were cryopreserved to allow the easier creation of SEs. Keratinocytes were seeded on thawed DEs, and SEs were constructed. Avian collagen increased the viability of DEs relative to the control. Furthermore, avian collagen increased the expression of PCNA and p63 in keratinocytes on thawed DEs. The results indicate that DEs containing avian collagen can be thawed as needed after cryopreservation. Avian collagen can improve the construction of SEs and be used as part of a dermal kit for SE construction.
    Type of Medium: Online Resource
    ISSN: 1422-6405 , 1422-6421
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2017
    detail.hit.zdb_id: 1481840-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Liver Cancer, S. Karger AG, Vol. 8, No. 1 ( 2019), p. 24-40
    Abstract: 〈 b 〉 〈 i 〉 Background and Aims: 〈 /i 〉 〈 /b 〉 The purpose of our study was to examine the histopathologic characteristics of hepatocellular carcinoma (HCC) with irregular rim-like arterial phase enhancement (IRE), which has been reported to be associated with more aggressive tumor behavior. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 We investigated 84 pathologically confirmed HCCs in 84 patients who underwent curative hepatic resection after gadoxetate-enhanced magnetic resonance imaging between January 2008 and February 2013. Two abdominal radiologists independently reviewed these images and classified HCCs into two categories: HCC showing IRE (IRE-HCC) and HCC showing hypoenhancement or diffuse arterial enhancement (non-IRE-HCC). Twenty-two HCCs were classified as IRE-HCCs, and 51 were classified as non-IRE-HCCs concordantly by both reviewers. The remaining 11 HCCs, on whose radiologic classifications the reviewers disagreed, were classified as HCCs with intermediate enhancement patterns. The HCC clinicopathologic characteristics and patient outcomes were then compared. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 IRE-HCCs showed more frequent microvascular invasion (91 vs. 35%), lower microvascular density (246.5 vs. 426.5/mm 〈 sup 〉 2 〈 /sup 〉 ), higher proportions of sinusoid-like microvascular pattern (55 vs. 0%) and macrotrabecular pattern (45 vs. 0%), and larger areas of tumor necrosis (15 vs. 0%) and fibrous stroma (8.3 vs. 2.1%) than non-IRE-HCCs. IRE-HCCs also expressed higher levels of immunomarkers of hypoxia (carbonic anhydrase IX, 64 vs. 8%) and stemness (EpCAM, 50 vs. 20%). 〈 i 〉 p 〈 /i 〉 values were & #x3c; 0.001 for all comparisons except for EpCAM ( 〈 i 〉 p 〈 /i 〉 = 0.026). HCCs with intermediate enhancement patterns showed mixed/intermediate pathologic features from both IRE- and non-IRE-HCCs. IRE-HCC patients showed poorer 5-year disease-free survival after curative resection than non-IRE-HCC patients ( 〈 i 〉 p 〈 /i 〉 = 0.005). 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 IRE-HCCs demonstrate aggressive histopathologic features, including more hypoxic and fibrotic tumor microenvironments and increased stemness, compared to non-IRE-HCCs. IRE might therefore serve as a noninvasive imaging biomarker for aggressive HCC.
    Type of Medium: Online Resource
    ISSN: 2235-1795 , 1664-5553
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2019
    detail.hit.zdb_id: 2666925-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Nephron Experimental Nephrology, S. Karger AG, Vol. 110, No. 2 ( 2008-9-8), p. e49-e58
    Abstract: 〈 i 〉 Background/Aims: 〈 /i 〉 Cyclosporine (CsA)-induced renal injury causes renal tubular acidosis. The current study was performed to evaluate the influence of CsA-induced renal injury on the ammonia transporter family members, Rh B-glycoprotein (Rhbg) and Rh C-glycoprotein (Rhcg). 〈 i 〉 Methods: 〈 /i 〉 Rats were treated daily for 1 or 4 weeks with vehicle (VH) or CsA. Induction of chronic CsA-induced nephropathy was confirmed by demonstrating impaired renal function and characteristic histopathology. Rhbg and Rhcg expression was evaluated with immunoblot, immunohistochemistry, real-time RT-PCR and electron microscopy. 〈 i 〉 Results: 〈 /i 〉 CsA treatment for 4 weeks developed mild metabolic acidosis and decreased urinary ammonia excretion. Rhcg mRNA expression was unchanged in both the cortex and outer medulla, but Rhcg protein expression in the CsA group was significantly reduced in the cortex and outer medulla. There were no significant differences in Rhbg mRNA and protein expression between the CsA and VH group. 〈 i 〉 Conclusion: 〈 /i 〉 Long-term treatment with CsA in rats results in decreased urinary ammonia excretion accompanied by decreased expression of Rhcg; these changes are likely to mediate the CsA-induced defect in ammonium excretion in the collecting duct.
    Type of Medium: Online Resource
    ISSN: 1660-2129
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2008
    detail.hit.zdb_id: 2098337-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Hormone Research in Paediatrics, S. Karger AG, Vol. 82, No. 4 ( 2014), p. 252-260
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 This study aimed to clarify the frequency, phenotypes, and molecular spectrum of 〈 i 〉 DUOX2 〈 /i 〉 , 〈 i 〉 TPO 〈 /i 〉 , 〈 i 〉 TSHR, 〈 /i 〉 and 〈 i 〉 TG 〈 /i 〉 mutations in patients with congenital hypothyroidism (CH) with enlarged or normal-sized eutopic thyroid glands. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 The study cohort included 43 subjects from 41 unrelated families who had CH with eutopic thyroid glands. Mutation analyses of 〈 i 〉 DUOX2 〈 /i 〉 , 〈 i 〉 TPO 〈 /i 〉 , and 〈 i 〉 TSHR 〈 /i 〉 were performed. The functional capacities of novel missense variants of 〈 i 〉 DUOX2 〈 /i 〉 were verified by measuring H 〈 sub 〉 2 〈 /sub 〉 O 〈 sub 〉 2 〈 /sub 〉 generation in vitro. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Of the 43 subjects, 23 (53.5%) had sequence variants in at least one gene. Twelve different 〈 i 〉 DUOX2 〈 /i 〉 variants, including seven novel variants, were identified in 20 subjects. A functional analysis of the 〈 i 〉 DUOX2 〈 /i 〉 variants revealed that most variants, other than p.G206V and p.H678R, caused a significant reduction in H 〈 sub 〉 2 〈 /sub 〉 O 〈 sub 〉 2 〈 /sub 〉 generation. Therefore, 15 subjects harbored functionally deleterious 〈 i 〉 DUOX2 〈 /i 〉 variants. Of these, 5 subjects had transient CH, and 10 were found to have permanent CH. Sequence variants in 〈 i 〉 TSHR 〈 /i 〉 were identified in 5 subjects. One of the 43 subjects (2.3%) had sequence variants in two different genes. 〈 b 〉 〈 i 〉 Conclusions: 〈 /i 〉 〈 /b 〉 〈 i 〉 DUOX2 〈 /i 〉 variants are a relatively common cause of CH with normal-sized or enlarged eutopic thyroid glands. Variable phenotypes were associated with partial loss of the functional activity of 〈 i 〉 DUOX2 〈 /i 〉 variants.
    Type of Medium: Online Resource
    ISSN: 1663-2818 , 1663-2826
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2014
    detail.hit.zdb_id: 2540224-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Cellular Physiology and Biochemistry, S. Karger AG, Vol. 27, No. 3-4 ( 2011), p. 353-362
    Type of Medium: Online Resource
    ISSN: 1421-9778 , 1015-8987
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2011
    detail.hit.zdb_id: 1482056-0
    SSG: 12
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    S. Karger AG ; 2016
    In:  Hormone Research in Paediatrics Vol. 85, No. 2 ( 2016), p. 131-139
    In: Hormone Research in Paediatrics, S. Karger AG, Vol. 85, No. 2 ( 2016), p. 131-139
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 This prospective study was conducted to investigate the feasibility of an early discontinuation of thyroid hormone treatment in very-low-birth-weight (VLBW) infants with congenital hypothyroidism (CH). 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 We enrolled VLBW infants between January 2011 and December 2012. The infants were divided into the hypothyroid and normal thyroid function groups according to the results of a thyroid function test. We performed an early off-therapy trial at 24 months of age. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 Of the 182 VLBW infants enrolled, 15 were lost to follow-up and 167 were finally enrolled. In total, 24 infants (14.4%) were assigned to the hypothyroid function group and were treated with thyroid hormone. Younger gestational age and a lower birth weight were associated with hypothyroid function. In the hypothyroid function group, hypothyroidism (HT) and hyperthyrotropinemia (HTT) were observed in 13 and 11 infants, respectively. There were no differences in the clinical characteristics between the HT and HTT groups. Overall, 24 infants discontinued thyroxine medication at 24 months of age after normal results had been confirmed by radiologic work-ups, including thyroid ultrasonography and technetium-99m scans. All infants were successfully weaned off thyroxine and maintained euthyroid function. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Early discontinuation of thyroid hormone replacement therapy is possible in the majority of VLBW infants with CH.
    Type of Medium: Online Resource
    ISSN: 1663-2818 , 1663-2826
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2016
    detail.hit.zdb_id: 2540224-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    In: Acta Haematologica, S. Karger AG, Vol. 122, No. 4 ( 2009), p. 200-210
    Abstract: 〈 i 〉 Aim: 〈 /i 〉 The Korean Multiple Myeloma Working Party performed a nationwide registration of multiple myeloma patients via a web-based data bank system. 〈 i 〉 Methods: 〈 /i 〉 We retrospectively analyzed registered data from 3,209 patients since 1999. 〈 i 〉 Results: 〈 /i 〉 The median overall survival (OS) was 50.13 months (95% confidence interval: 46.20–54.06 months). Patients ≤40 years demonstrated a longer OS than patients 〉 65 years of age (median OS 71.13 vs. 36.73 months, p 〈 0.001). Patients who received novel agents at any time during their treatments showed a longer OS than patients who did not (median OS 42.23 vs. 55.50 months, p 〈 0.001). Response to treatment was associated with OS, with tandem autologous stem cell transplantation (SCT) producing longer OS than single autologous SCT. 〈 i 〉 Conclusions: 〈 /i 〉 We demonstrated associations between survival outcomes and treatment modalities as well as baseline disease characteristics in a registry of multiple myeloma patients using a web-based data analysis.
    Type of Medium: Online Resource
    ISSN: 0001-5792 , 1421-9662
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2009
    detail.hit.zdb_id: 1481888-7
    detail.hit.zdb_id: 80008-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Medical Principles and Practice, S. Karger AG, Vol. 30, No. 6 ( 2021), p. 527-534
    Abstract: 〈 b 〉 〈 i 〉 Objective: 〈 /i 〉 〈 /b 〉 The objective of this study is to evaluate irritable bowel syndrome (IBS) as a risk factor for osteoporosis and osteoporotic fracture in Korean women after controlling for basic confounding factors and considering detailed demographic and clinical information. 〈 b 〉 〈 i 〉 Subjects and Methods: 〈 /i 〉 〈 /b 〉 We performed a nationwide population-based retrospective cohort analysis and matched every IBS case with a non-IBS case at a 1:4 frequency ratio based on age. The population consisted of female patients with data in the Health Insurance Review and Assessment (HIRA) database from 2002 to 2010. To determine the risk of osteoporosis and osteoporotic fracture in IBS and non-IBS patients, hazard ratios (HRs) with 95% confidence intervals (CI) were estimated using Cox proportional hazards regression models, adjusting for confounding variables, such as the area of residence, health insurance type, and economic status. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 We identified 1,017,468 patients in the HIRA database with data from 2002 to 2010 who could potentially be included in the cohort. Among these, we identified 1,545 (11.4%) women (age & #x3e;19 years) with newly diagnosed IBS (IBS group). Additionally, 6,180 patients without IBS and age-matched to the IBS group were selected. Cox modeling revealed that the crude HRs for osteoporosis and osteoporotic fractures in patients with IBS were 1.476 (95% CI, 1.241–1.754) and 1.427 (95% CI, 1.086–1.876), respectively. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 Our data showed an increased incidence of osteoporosis and osteoporotic fractures in women with IBS compared with age-matched controls.
    Type of Medium: Online Resource
    ISSN: 1011-7571 , 1423-0151
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2021
    detail.hit.zdb_id: 1482963-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Case Reports in Nephrology and Dialysis, S. Karger AG, Vol. 5, No. 3 ( 2015-9-2), p. 180-186
    Abstract: Monoclonal gammopathy with undetermined significance (MGUS) carries a risk of progression to multiple myeloma, and progression is usually diagnosed with changes in M-protein or bone marrow biopsy. We report a case of 62-year-old female patient showing MGUS progression to multiple myeloma without significant changes in M-protein but diagnosed by kidney biopsy. During the follow-ups, azotemia and tubular proteinuria were aggravated without elevation of M-protein. Kidney biopsy showed intratubular and glomerular inclusions associated with plasma cell dysplasia. The progression of MGUS to multiple myeloma was diagnosed by this kidney biopsy. The patient's renal function and tubular proteinuria were markedly improved after chemotherapy.
    Type of Medium: Online Resource
    ISSN: 2296-9705
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2015
    detail.hit.zdb_id: 2809879-1
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...